Mavegda
Любителям "инновационного"
Background Dupilumab, a human monoclonal antibody targeting the interleukin 4 alpha receptor, is used for treatment of moderate to severe atopic dermatitis (AD). Previous studies have reported diagnoses of cutaneous T cell lymphoma (CTCL) after dupilumab use. Objective Investigate the risk of CTCL after dupilumab use in patients with…